Mach7 Technologies Limited
Mach7 Technologies Limited M7T.AX Peers
See (M7T.AX) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| M7T.AX | A$0.34 | +0.00% | 80.8M | -16.75 | -A$0.02 | N/A |
| PME.AX | A$285.20 | +0.00% | 32.1B | 327.01 | A$0.94 | +0.15% |
| VHT.AX | A$1.15 | +0.44% | 291.3M | -28.63 | -A$0.04 | N/A |
| CGS.AX | A$1.70 | +0.00% | 278.5M | 23.57 | A$0.07 | N/A |
| ONE.AX | A$0.25 | +0.00% | 204.6M | -8.67 | -A$0.03 | N/A |
| ALC.AX | A$0.10 | +0.00% | 134.3M | -10.00 | -A$0.01 | N/A |
| SHG.AX | A$0.38 | +0.00% | 104.1M | -18.75 | -A$0.02 | N/A |
| AYA.AX | A$0.70 | +0.00% | 90.3M | -4.44 | -A$0.18 | N/A |
| PCK.AX | A$0.04 | +0.00% | 77.4M | -4.20 | -A$0.01 | N/A |
| BMT.AX | A$0.24 | +0.00% | 68.2M | -11.75 | -A$0.02 | N/A |
Stock Comparison
M7T.AX vs PME.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, PME.AX has a market cap of 32.1B. Regarding current trading prices, M7T.AX is priced at A$0.34, while PME.AX trades at A$285.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas PME.AX's P/E ratio is 327.01. In terms of profitability, M7T.AX's ROE is -0.10%, compared to PME.AX's ROE of +0.48%. Regarding short-term risk, M7T.AX is more volatile compared to PME.AX. This indicates potentially higher risk in terms of short-term price fluctuations for M7T.AX.
M7T.AX vs VHT.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, VHT.AX has a market cap of 291.3M. Regarding current trading prices, M7T.AX is priced at A$0.34, while VHT.AX trades at A$1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas VHT.AX's P/E ratio is -28.63. In terms of profitability, M7T.AX's ROE is -0.10%, compared to VHT.AX's ROE of -0.18%. Regarding short-term risk, M7T.AX is more volatile compared to VHT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for M7T.AX.
M7T.AX vs CGS.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, CGS.AX has a market cap of 278.5M. Regarding current trading prices, M7T.AX is priced at A$0.34, while CGS.AX trades at A$1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas CGS.AX's P/E ratio is 23.57. In terms of profitability, M7T.AX's ROE is -0.10%, compared to CGS.AX's ROE of +0.20%. Regarding short-term risk, M7T.AX is more volatile compared to CGS.AX. This indicates potentially higher risk in terms of short-term price fluctuations for M7T.AX.
M7T.AX vs ONE.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, ONE.AX has a market cap of 204.6M. Regarding current trading prices, M7T.AX is priced at A$0.34, while ONE.AX trades at A$0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas ONE.AX's P/E ratio is -8.67. In terms of profitability, M7T.AX's ROE is -0.10%, compared to ONE.AX's ROE of -1.17%. Regarding short-term risk, M7T.AX is more volatile compared to ONE.AX. This indicates potentially higher risk in terms of short-term price fluctuations for M7T.AX.
M7T.AX vs ALC.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, ALC.AX has a market cap of 134.3M. Regarding current trading prices, M7T.AX is priced at A$0.34, while ALC.AX trades at A$0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas ALC.AX's P/E ratio is -10.00. In terms of profitability, M7T.AX's ROE is -0.10%, compared to ALC.AX's ROE of -0.06%. Regarding short-term risk, M7T.AX is less volatile compared to ALC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for M7T.AX.
M7T.AX vs SHG.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, SHG.AX has a market cap of 104.1M. Regarding current trading prices, M7T.AX is priced at A$0.34, while SHG.AX trades at A$0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas SHG.AX's P/E ratio is -18.75. In terms of profitability, M7T.AX's ROE is -0.10%, compared to SHG.AX's ROE of -0.80%. Regarding short-term risk, M7T.AX is less volatile compared to SHG.AX. This indicates potentially lower risk in terms of short-term price fluctuations for M7T.AX.
M7T.AX vs AYA.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, AYA.AX has a market cap of 90.3M. Regarding current trading prices, M7T.AX is priced at A$0.34, while AYA.AX trades at A$0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas AYA.AX's P/E ratio is -4.44. In terms of profitability, M7T.AX's ROE is -0.10%, compared to AYA.AX's ROE of -0.92%. Regarding short-term risk, M7T.AX is more volatile compared to AYA.AX. This indicates potentially higher risk in terms of short-term price fluctuations for M7T.AX.
M7T.AX vs PCK.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, PCK.AX has a market cap of 77.4M. Regarding current trading prices, M7T.AX is priced at A$0.34, while PCK.AX trades at A$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas PCK.AX's P/E ratio is -4.20. In terms of profitability, M7T.AX's ROE is -0.10%, compared to PCK.AX's ROE of -4.53%. Regarding short-term risk, M7T.AX is less volatile compared to PCK.AX. This indicates potentially lower risk in terms of short-term price fluctuations for M7T.AX.
M7T.AX vs BMT.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, BMT.AX has a market cap of 68.2M. Regarding current trading prices, M7T.AX is priced at A$0.34, while BMT.AX trades at A$0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas BMT.AX's P/E ratio is -11.75. In terms of profitability, M7T.AX's ROE is -0.10%, compared to BMT.AX's ROE of -0.12%. Regarding short-term risk, M7T.AX is more volatile compared to BMT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for M7T.AX.
M7T.AX vs DOC.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, DOC.AX has a market cap of 42.2M. Regarding current trading prices, M7T.AX is priced at A$0.34, while DOC.AX trades at A$0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas DOC.AX's P/E ratio is -3.83. In terms of profitability, M7T.AX's ROE is -0.10%, compared to DOC.AX's ROE of -5.56%. Regarding short-term risk, M7T.AX is more volatile compared to DOC.AX. This indicates potentially higher risk in terms of short-term price fluctuations for M7T.AX.
M7T.AX vs MDR.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, MDR.AX has a market cap of 40.6M. Regarding current trading prices, M7T.AX is priced at A$0.34, while MDR.AX trades at A$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas MDR.AX's P/E ratio is -6.50. In terms of profitability, M7T.AX's ROE is -0.10%, compared to MDR.AX's ROE of -0.09%. Regarding short-term risk, M7T.AX is less volatile compared to MDR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for M7T.AX.
M7T.AX vs COO.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, COO.AX has a market cap of 26.3M. Regarding current trading prices, M7T.AX is priced at A$0.34, while COO.AX trades at A$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas COO.AX's P/E ratio is N/A. In terms of profitability, M7T.AX's ROE is -0.10%, compared to COO.AX's ROE of -0.05%. Regarding short-term risk, M7T.AX is more volatile compared to COO.AX. This indicates potentially higher risk in terms of short-term price fluctuations for M7T.AX.
M7T.AX vs RHT.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, RHT.AX has a market cap of 18.4M. Regarding current trading prices, M7T.AX is priced at A$0.34, while RHT.AX trades at A$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas RHT.AX's P/E ratio is N/A. In terms of profitability, M7T.AX's ROE is -0.10%, compared to RHT.AX's ROE of -0.03%. Regarding short-term risk, M7T.AX is more volatile compared to RHT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for M7T.AX.
M7T.AX vs IME.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, IME.AX has a market cap of 15.8M. Regarding current trading prices, M7T.AX is priced at A$0.34, while IME.AX trades at A$0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas IME.AX's P/E ratio is -4.92. In terms of profitability, M7T.AX's ROE is -0.10%, compared to IME.AX's ROE of -0.18%. Regarding short-term risk, M7T.AX is more volatile compared to IME.AX. This indicates potentially higher risk in terms of short-term price fluctuations for M7T.AX.
M7T.AX vs 1ST.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, 1ST.AX has a market cap of 15.6M. Regarding current trading prices, M7T.AX is priced at A$0.34, while 1ST.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas 1ST.AX's P/E ratio is -1.10. In terms of profitability, M7T.AX's ROE is -0.10%, compared to 1ST.AX's ROE of +0.69%. Regarding short-term risk, M7T.AX is more volatile compared to 1ST.AX. This indicates potentially higher risk in terms of short-term price fluctuations for M7T.AX.
M7T.AX vs EMD.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, EMD.AX has a market cap of 13.3M. Regarding current trading prices, M7T.AX is priced at A$0.34, while EMD.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas EMD.AX's P/E ratio is -0.90. In terms of profitability, M7T.AX's ROE is -0.10%, compared to EMD.AX's ROE of -0.56%. Regarding short-term risk, M7T.AX is less volatile compared to EMD.AX. This indicates potentially lower risk in terms of short-term price fluctuations for M7T.AX.
M7T.AX vs OPL.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, OPL.AX has a market cap of 6.8M. Regarding current trading prices, M7T.AX is priced at A$0.34, while OPL.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas OPL.AX's P/E ratio is -2.90. In terms of profitability, M7T.AX's ROE is -0.10%, compared to OPL.AX's ROE of +12.65%. Regarding short-term risk, M7T.AX is less volatile compared to OPL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for M7T.AX.
M7T.AX vs HIQ.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, HIQ.AX has a market cap of 5.7M. Regarding current trading prices, M7T.AX is priced at A$0.34, while HIQ.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas HIQ.AX's P/E ratio is -1.40. In terms of profitability, M7T.AX's ROE is -0.10%, compared to HIQ.AX's ROE of +2.49%. Regarding short-term risk, M7T.AX is less volatile compared to HIQ.AX. This indicates potentially lower risk in terms of short-term price fluctuations for M7T.AX.
M7T.AX vs MEB.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, MEB.AX has a market cap of 4.5M. Regarding current trading prices, M7T.AX is priced at A$0.34, while MEB.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas MEB.AX's P/E ratio is -0.10. In terms of profitability, M7T.AX's ROE is -0.10%, compared to MEB.AX's ROE of -0.47%. Regarding short-term risk, M7T.AX is less volatile compared to MEB.AX. This indicates potentially lower risk in terms of short-term price fluctuations for M7T.AX.
M7T.AX vs TD1.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, TD1.AX has a market cap of 4.1M. Regarding current trading prices, M7T.AX is priced at A$0.34, while TD1.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas TD1.AX's P/E ratio is -0.10. In terms of profitability, M7T.AX's ROE is -0.10%, compared to TD1.AX's ROE of -0.24%. Regarding short-term risk, M7T.AX is more volatile compared to TD1.AX. This indicates potentially higher risk in terms of short-term price fluctuations for M7T.AX.
M7T.AX vs GLH.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, GLH.AX has a market cap of 4M. Regarding current trading prices, M7T.AX is priced at A$0.34, while GLH.AX trades at A$0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas GLH.AX's P/E ratio is -6.80. In terms of profitability, M7T.AX's ROE is -0.10%, compared to GLH.AX's ROE of +0.27%. Regarding short-term risk, M7T.AX is more volatile compared to GLH.AX. This indicates potentially higher risk in terms of short-term price fluctuations for M7T.AX.
M7T.AX vs ICR.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, ICR.AX has a market cap of 3.4M. Regarding current trading prices, M7T.AX is priced at A$0.34, while ICR.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas ICR.AX's P/E ratio is -0.70. In terms of profitability, M7T.AX's ROE is -0.10%, compared to ICR.AX's ROE of -10.86%. Regarding short-term risk, M7T.AX is less volatile compared to ICR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for M7T.AX.
M7T.AX vs CTQ.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, CTQ.AX has a market cap of 2.6M. Regarding current trading prices, M7T.AX is priced at A$0.34, while CTQ.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas CTQ.AX's P/E ratio is -1.10. In terms of profitability, M7T.AX's ROE is -0.10%, compared to CTQ.AX's ROE of -0.62%. Regarding short-term risk, M7T.AX is more volatile compared to CTQ.AX. This indicates potentially higher risk in terms of short-term price fluctuations for M7T.AX.
M7T.AX vs OAK.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, OAK.AX has a market cap of 2.2M. Regarding current trading prices, M7T.AX is priced at A$0.34, while OAK.AX trades at A$0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas OAK.AX's P/E ratio is -2.00. In terms of profitability, M7T.AX's ROE is -0.10%, compared to OAK.AX's ROE of -0.44%. Regarding short-term risk, M7T.AX is more volatile compared to OAK.AX. This indicates potentially higher risk in terms of short-term price fluctuations for M7T.AX.
M7T.AX vs JTL.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, JTL.AX has a market cap of 281.3K. Regarding current trading prices, M7T.AX is priced at A$0.34, while JTL.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas JTL.AX's P/E ratio is -0.10. In terms of profitability, M7T.AX's ROE is -0.10%, compared to JTL.AX's ROE of +0.60%. Regarding short-term risk, M7T.AX is more volatile compared to JTL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for M7T.AX.
M7T.AX vs TTB.AX Comparison
M7T.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, M7T.AX stands at 80.8M. In comparison, TTB.AX has a market cap of 267.4K. Regarding current trading prices, M7T.AX is priced at A$0.34, while TTB.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
M7T.AX currently has a P/E ratio of -16.75, whereas TTB.AX's P/E ratio is -0.02. In terms of profitability, M7T.AX's ROE is -0.10%, compared to TTB.AX's ROE of -1.05%. Regarding short-term risk, M7T.AX is more volatile compared to TTB.AX. This indicates potentially higher risk in terms of short-term price fluctuations for M7T.AX.